Prosecution Insights
Last updated: April 19, 2026

Examiner: PAGONAKIS, ANNA

Tech Center 6200 • Art Units: 1600 1614 1628 6221

This examiner grants 38% of resolved cases

Performance Statistics

38.4%
Allow Rate
-21.6% vs TC avg
956
Total Applications
+11.9%
Interview Lift
1123
Avg Prosecution Days
Based on 952 resolved cases, 2023–2026

Rejection Statute Breakdown

0.9%
§101 Eligibility
16.4%
§102 Novelty
40.4%
§103 Obviousness
26.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18278259 CYCLIC CELL-PENETRATING PEPTIDES WITH THREE OR MORE HYDROPHOBIC RESIDUES Non-Final OA Ohio State Innovation Foundation
18563879 INSECT PROTEIN COMPOSITION FOR THE PREVENTION AND TREATMENT OF CONDITIONS RELATED TO INTESTINAL OXIDATIVE STRESS DAMAGE Non-Final OA Protix B.V.
18468506 DOSING REGIMENS FOR HEMATOPOIETIC STEM CELL MOBILIZATION FOR STEM CELL TRANSPLANTS IN MULTIPLE MYELOMA PATIENTS Non-Final OA Ensoma, Inc.
18550192 GEL BASED ON ANNELID HEMOGLOBIN Non-Final OA HEMARINA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month